Evaluation of the Activity of Lippia alba Leave Extract in Reducing Ochratoxin A in Albino Rats
Journal Title: Journal of Advances in Medical and Pharmaceutical Sciences - Year 2017, Vol 15, Issue 1
Abstract
Ochratoxin A is a metabolite of fungal origin with the potential of inciting oxidative stress which results in disease conditions in man and animals. Plant parts from time immemorial have been used to treat disease conditions with considerable success, hence the study is aimed at determining the capacity of Lippia alba leaf extract to reduce the concentration of ochratoxin A in animal serum, kidney, and liver. Albino rats (60) were obtained and maintained, then divided into pre-treated set which were administered plant extract before toxin administration intraperitoneally, and post-treated set administered the toxin then treated with the plant extract. After 7 days of treatment and observation, the animals were euthanized, serum collected, and the organs harvested. Ochratoxin A concentration was determined using HPLC. Results obtained showed that serum of animals in group 5 treated with L. alba extract after toxin administration reduced OTA levels to 0.12 ± 0.06 ng/mL in the pre-treated set, while 0.58 ± 0.01 ng/mL was obtained in the post-treated set. The livers of pre-treated animals presented a 75% reduction in ochratoxin A concentration level compared to post-treated set that obtained 59.57% ochratoxin A reduction. Kidney toxins levels were lower than values obtained in the liver and serum. Though considerable reductions in ochratoxin A levels were recorded in the kidney, there was no significant difference from the control at p<0.05 in values obtained between the post-treated and pre-treat sets unlike values obtained in the serum and liver that presented significant differences at p<0.05. The study concluded that the plant possesses therapeutic capabilities which brought about the effects noted in the study. It is recommended that further study be undertaken to unravel the other potentials of the plant and mechanism of action.
Authors and Affiliations
Olukayode Olugbenga Orole, Timothy Olubisi Adejumo, Japhet Erasmus Aisoni
Keywords
Related Articles
- EP ID EP313194
- DOI 10.9734/JAMPS/2017/35875
- Views 107
- Downloads 0
Comparative Studies on the Effects of Zidovudine, Nevirapine, Lamivudine and Bioclean II on Female HIV/AIDS Cases in Nigeria
Definite cure for HIV/AIDS is not yet documented and over 40 million people in the world are believed to be infected with the virus. The present study evaluates the effects of Zidovudine + Lamivudine + Nevirapine (HAART)...
Proactive Nursing Care is the Key to Successful Day Case Laparoscopic Cholecystectomy at a Rural Hospital
Aim: Day case laparoscopic cholecystectomy is achievable but in most hospitals it is not routine. We describe our experience with day case laparoscopic cholecystectomy in a rural Queensland hospital. Methods: Retrospecti...
Development and Estimation of an in Silico Model for Anti-HIV-1 Integrase Inhibitor Using Genetic Function Approximation
Aim: Integrase inhibitors are an essential enzyme required for replication of the acquired immunodeficiency syndrome virus. It is a potent target for anti- HIV therapy. A QSAR study is performed on the series indole β-di...
The Effect of Silymarin on Serum Concentration of Soluble Apoptosis Markers in β-Thalassemia Major Patients Receiving Desferrioxamine
Background: Despite appropriate chelation therapy with desferrioxamine, iron deposition in visceral organs causes tissue damage in thalassemia major patients. Excess iron can generate reactive oxygen species (ROS) that m...
Development and Validation of Stability Indicating UFLC Method for the Estimation of Anti-spasmodic Drug - Valethamate Bromide
A stability indicating Ultra-Fast Liquid Chromatography (UFLC) method has been developed to estimate valethamate bromide (V&B) in tablet dosage forms and to separate analyte from other degradants and to carryout forced d...